Skip to main content

Africa-Europe Health Partnership to Strengthen Health Research on Mpox and Lassa fever: Sharing the experiences of the Partnership Fellows

12th June 2026

Seven early and mid-career researchers based at universities and research performing organisations in Malawi, Uganda, Nigeria, and Ghana share their experiences as fellows of the AU-EU Health Partnership to strengthen research on mpox and Lassa fever.

Earlier this year, we announced that these seven researchers had begun their placements as part of a fellowship programme under the Team Europe Initiative on manufacturing and access to vaccines, medicines and health technologies in Africa initiative. The programme is jointly led by the African Research Universities Alliance (ARUA), The Guild of European Research-Intensive Universities (The Guild), and Enabel, and is funded by the Belgian government within the broader Team Europe approach.

The fellowship aims to build Africa’s capacity in translational research and vaccine development, responding to the urgent need for African-led solutions to emerging and re-emerging infectious diseases.

The first cohort took part in a mobility scheme consisting of multiple short research stays, ranging from a week to six weeks at host institutions across Europe and Africa, including the University of Ghana, the University of Ibadan, Makerere University, University of Bern, Radboud University Medical Centre, University of Glasgow, and Universitat Pompeu Fabra.

We interviewed each fellow about their experience. Click their names below to read more about their research stays:

SHARE THIS ARTICLE: